Diazepam
Appearance
![]() | |
---|---|
![]() | |
Systematic (IUPAC) name | |
7-Chloro-1,3-dihydro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one[1] | |
Clinical data | |
Trade names | Valium, Vazepam, others[1] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682047 |
Licence data | US FDA:link |
Pregnancy cat. | C (AU) D (US) |
Legal status | Prescription Only (S4) (AU) Schedule IV (CA) P.O.M otherwise Class C (UK) Schedule IV (US) Psychotropic schedule IV (UN) ℞ Prescription only |
Dependence liability | Moderate |
Routes | By mouth, IM, IV, rectal |
Pharmacokinetic data | |
Bioavailability | 76% (64–97%) by mouth, 81% (62–98%) rectal[2] |
Metabolism | Liver—CYP2B6 (minor route) to desmethyldiazepam, CYP2C19 (major route) to inactive metabolites, CYP3A4 (major route) to desmethyldiazepam |
Half-life | (50 hours); 20–100 hours (36–200 hours for main active metabolite desmethyldiazepam) |
Excretion | Kidney |
Identifiers | |
CAS number | 439-14-5 ![]() |
ATC code | N05BA01 |
PubChem | CID 3016 |
IUPHAR ligand | 3364 |
DrugBank | DB00829 |
ChemSpider | 2908 ![]() |
UNII | Q3JTX2Q7TU ![]() |
KEGG | D00293 ![]() |
ChEBI | CHEBI:49575 ![]() |
ChEMBL | CHEMBL12 ![]() |
Chemical data | |
Formula | C16H13ClN2O |
| |
| |
![]() |
Diazepam (ඩයසිපෑම්) යනු බෙන්සොඩයසපීන (benzodiazepine) පවුලට අයත් ඖෂධයකි.[3] [4]
මූලාශ්ර
[සංස්කරණය]- ^ a b "National Highway Traffic Safety Administration Drugs and Human Performance Fact Sheet- Diazepam". 2017-03-27 දින මුල් පිටපත වෙතින් සංරක්ෂණය කරන ලදී. සම්ප්රවේශය 2017-11-13.
{{cite web}}
: Unknown parameter|dead-url=
ignored (|url-status=
suggested) (help) - ^ Dhillon, S; Oxley, J; Richens, A (1 March 1982). "Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients". British Journal of Clinical Pharmacology. 13 (3): 427–432. doi:10.1111/j.1365-2125.1982.tb01397.x. ISSN 0306-5251. PMC 1402110. PMID 7059446.
- ^ "විෂ නසන දේත් විෂ වෙයිද?". දිවයින. සම්ප්රවේශය 2018-08-29.
- ^ "දරුවන්ට උණවලිප්පුව ඇතිවන හැටි". දිවයින. සම්ප්රවේශය 2018-08-29.